Check-Cap Ltd
Company Profile
Business description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
Contact
29 Abba Hushi Avenue
Check-Cap Building, P.O. Box 1271
Isfiya3009000
ISRT: +972 48303400
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
85
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,456.80 | 15.00 | -0.18% |
CAC 40 | 7,423.67 | 15.03 | 0.20% |
DAX 40 | 20,271.33 | 138.48 | 0.69% |
Dow JONES (US) | 42,518.28 | 221.16 | 0.52% |
FTSE 100 | 8,201.54 | 22.65 | -0.28% |
HKSE | 19,238.39 | 18.61 | 0.10% |
NASDAQ | 19,044.39 | 43.71 | -0.23% |
Nikkei 225 | 38,384.61 | 89.69 | -0.23% |
NZX 50 Index | 12,943.57 | 59.19 | 0.46% |
S&P 500 | 5,842.91 | 6.69 | 0.11% |
S&P/ASX 200 | 8,213.30 | 17.70 | -0.22% |
SSE Composite Index | 3,228.61 | 12.33 | -0.38% |